An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases

The CSF-470 vaccine (VACCIMEL) plus BCG and GM-CSF as adjuvants has been assayed in cutaneous melanoma patients. In the adjuvant randomized Phase II study CASVAC-0401, vaccinated patients had longer distant metastasis-free survival (DMFS) than those treated with IFNα2b. Five years after locking the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mordoh, Ana, Aris, Mariana, Carri, Ibel, Bravo, Alicia Inés, Podaza, Enrique, Pardo, Juan Carlos Triviño, Cueto, Gerardo Rubén, Barrio, María Marcela, Mordoh, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011367/
https://www.ncbi.nlm.nih.gov/pubmed/35432383
http://dx.doi.org/10.3389/fimmu.2022.842555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011367/
https://www.ncbi.nlm.nih.gov/pubmed/35432383
http://dx.doi.org/10.3389/fimmu.2022.842555

Ejemplares similares